Search

Your search keyword '"Van Den Braak N"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Van Den Braak N" Remove constraint Author: "Van Den Braak N"
93 results on '"Van Den Braak N"'

Search Results

1. Phenotype spectrum of idiopathic small fiber neuropathies – Experience from a prospective registry study (n > 200)

7. Sequence Typing Confirms that Campylobacter jejuni Strains Associated with Guillain-Barré and Miller-Fisher Syndromes Are of Diverse Genetic Lineage, Serotype, and Flagella Type

9. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands

10. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher Syndroms

17. Structure Of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity And Clinical Features Of Guillain-Barre, And Miller Fisher Patients

21. The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital.

22. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

23. Structure of Campylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients

24. Sequence Typing Confirms that Campylobacter jejuniStrains Associated with Guillain-Barre´ and Miller-Fisher Syndromes Are of Diverse Genetic Lineage, Serotype, and Flagella Type

26. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis

27. Vancomycin-resistant enterococci in cats and dogs.

28. Structure Of Campylobacter Jejuni Lipopolysaccharides Determines Antiganglioside Specificity And Clinical Features Of Guillain-Barre, And Miller Fisher Patients.

29. SEQUENCE TYPING CONFIRMS THAT CAMPYLOBACTER JEJUNI STRAINS ASSOCIATED WITH GUILLAIN-BARRÉ AND MILLER-FISHER SYNDROMES ARE OF DIVERSE GENETIC LINEAGE, SEROTYPE, AND FLAGELLA TYPE.

30. Variable flagella expression among clonal toxin A– /B+ Clostridium difficile strains with highly homogeneous flagellin genes.

31. Painful stimulation increases functional connectivity between supplementary motor area and thalamus in patients with small fibre neuropathy.

32. Reduced Gray Matter Volume and Cortical Thickness in Patients With Small-Fiber Neuropathy.

33. Genotype-phenotype relationships as prognosticators in Rett syndrome should be handled with care in clinical practice.

34. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.

35. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.

36. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

37. A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis.

38. Risk factors associated with Campylobacter jejuni infections in Curaçao, Netherlands Antilles.

39. Molecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles.

40. Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea.

41. Variable flagella expression among clonal toxin A-/B+Clostridium difficile strains with highly homogeneous flagellin genes.

42. Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea.

43. Isolation and identification of Campylobacter species by use of selective enrichment, nucleic acid amplification methods, and gene probes.

44. A Campylobacter jejuni gene associated with immune-mediated neuropathy.

45. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

46. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.

47. Host specificity of vancomycin-resistant Enterococcus faecium.

48. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands.

49. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

50. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Catalog

Books, media, physical & digital resources